Sky Labs' 'Cart Blood Pressure Monitor' Proven Effective in Measuring Blood Pressure in Zero-Gravity Environment
Predicted impact: Low
Zero-gravity blood pressure accuracy result already reported in recent days
Sky Labs스카이랩스
386380 · KOSDAQ · ₩386380 · 스카이랩스
₩11,190▲ ₩180 (1.63%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y −52.38%
- Market cap
- ₩210B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- —
- ROE
- —
- Net margin
- —
Financial statements not available yet.
52-week range−71.6% from the high
₩8,200Today: ₩11,100 – ₩12,120₩39,350
Returns
- 1W−1.4%
- 1M−48.1%
- 3M—
- 6M—
- YTD−52.4%
- 1Y—
- Volume today
- 649,886
- 0.6× the 20-day average
- Traded today
- ₩7.5B
- Listed shares
- 18,761,977
- EPS (12 months)
- —
AI researchResearch not started yetResearch starts once this company's financial statements are available.IPOListed Sep 4, 2026 at ₩10,000IPO details →
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: Positive product validation news, with no price or financial figures given. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-51.2% over the last month; the price is below its 20-day average.
- News impactLow8 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Sky Labs stock overview
Sky Labs (스카이랩스, KRX: 386380) is listed on KOSDAQ, in the Medical & precision devices sector. Its shares closed at ₩11,190 on Oct 28, 2026, up 1.63% on the day, giving it a market value of ₩210B.
Key facts
- Market cap
- ₩210B
- Sector
- Medical & precision devices
- Latest price change
- +1.63%
- As of
- Oct 28, 2026
Quick answers about Sky Labs
- What is the market cap of Sky Labs?
- The market capitalisation of Sky Labs was ₩210B at the close on Oct 28, 2026.
- Who are the largest shareholders of Sky Labs?
- According to the latest official filings, the largest reported holders are Lee Byung-hwan (40.05%, as of Oct 14, 2026); Moru Asset Management (8.69%, as of Sep 11, 2026); Korea Development Bank (7.51%, as of Sep 7, 2026).
Company profile
Loading data for this company — check back soon
- Korean name
- 스카이랩스
- Themes
- Medical devices
- CEO
- 이병환
- Founded
- Sep 2015
- Listed
- Sep 2026
- Listed shares
- 18,761,977
- Fiscal year ends
- Month 12
- Website
- www.skylabs.io/
Similar companies
- TSE131290 · ₩3T₩275,000+5.77%
- Kctech281820 · ₩1.9T₩95,500+3.92%
- Classys214150 · ₩1.8T₩27,000+1.89%
- Park Systems140860 · ₩1.6T₩229,500+1.77%
- DI003160 · ₩1.2T₩43,300+14.55%
- LivsMed491000 · ₩1.1T₩43,650+17.65%
- Curiox Biosystems445680 · ₩1.1T₩62,400+0.16%
- Seers458870 · ₩943B₩24,600−6.46%
Recent news
Sky Labs Verifies Blood Pressure Measurement Accuracy in Zero-Gravity Conditions
Predicted impact: Low
Blood pressure accuracy verification; no revenue or financial impact disclosed.
[Yeouido Investment HQ Part 2] Korea Circuit vs SkyLabs vs Neosem vs Myungshin Industry — What's the Strategy?
Predicted impact: Low
Strategy roundup repeating earlier Q3 profit-increase and SoCAMM expectations already reported.
Recent filings
See all- 5%+ holding reportOct 14, 2026
- Major sales or supply contractOct 1, 2026
- 5%+ holding reportSep 11, 2026
- 5%+ holding reportSep 11, 2026
- Insider shareholding reportSep 11, 2026
Titles in Korean until English translations are added.
Also known as: Sky Labs / 스카이랩스 / 386380 / KRX:386380
Source: KRX statistical information